Has a 3-fold decreased dose of bacillus Calmette-Guerin the same efficacy against recurrences and progression of T1G3 and Tis bladder tumors than the standard dose? Results of a prospective randomized trial.

MLA

Martínez-Piñeiro, José A., et al. “Has a 3-Fold Decreased Dose of Bacillus Calmette-Guerin the Same Efficacy against Recurrences and Progression of T1G3 and Tis Bladder Tumors than the Standard Dose? Results of a Prospective Randomized Trial.” The Journal of Urology, vol. 174, no. 4 Pt 1, Oct. 2005, pp. 1242–47. EBSCOhost, https://doi.org/10.1097/01.ju.0000173919.28835.aa.

APA

Martínez-Piñeiro, J. A., Martínez-Piñeiro, L., Solsona, E., Rodríguez, R. H., Gómez, J. M. F., Martín, M. G., Molina, J. R., Collado, A. G., Flores, N., Isorna, S., Pertusa, C., Rabadán, M., Astobieta, A., Camacho, J. E., Arribas, S., & Madero, R. (2005). Has a 3-fold decreased dose of bacillus Calmette-Guerin the same efficacy against recurrences and progression of T1G3 and Tis bladder tumors than the standard dose? Results of a prospective randomized trial. The Journal of Urology, 174(4 Pt 1), 1242–1247. https://doi.org/10.1097/01.ju.0000173919.28835.aa

Chicago

Martínez-Piñeiro, José A, Luis Martínez-Piñeiro, Eduardo Solsona, Rafael Hernández Rodríguez, Jesús María Fernández Gómez, Marcelino González Martín, Jesús Rodríguez Molina, et al. 2005. “Has a 3-Fold Decreased Dose of Bacillus Calmette-Guerin the Same Efficacy against Recurrences and Progression of T1G3 and Tis Bladder Tumors than the Standard Dose? Results of a Prospective Randomized Trial.” The Journal of Urology 174 (4 Pt 1): 1242–47. doi:10.1097/01.ju.0000173919.28835.aa.